FIELD: medicine, microbiology, immunology. SUBSTANCE: invention relates to the use of the known strain Bacillus anthracis 81/1 as the high-virulent test-infecting culture for evaluation of immunogenicity of vaccines CTИ in vaccinated animal based on immunity index and this strain can be useful for this aim. The protection percent as a difference between percent of survived vaccinated animals and control ones is 7.0 ± 5.9 at the infection dose 10 DCL and 42 ± 9.0 at the infection dose 50 DCL. EFFECT: improved method of assay. 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SELECTION OF ANTHRAX VACCINE STRAIN CULTURES AND VACCINES PREPARED OF THEREOF | 1995 |
|
RU2123532C1 |
METHOD OF DIFFERENTIATION OF ANTHRAX MICROBE STRAINS BY VIRULENCE IN VITRO | 1995 |
|
RU2101351C1 |
METHOD OF VIRULENCE RECOVERY OF ANTHRAX MICROBE STRAINS | 1995 |
|
RU2102484C1 |
METHOD OF SELECTION OF IMMUNOGENIC STRAINS AND SUBCULTURES OF LIVE ANTHRAX VACCINES | 1995 |
|
RU2101355C1 |
METHOD OF ANTHRAX TOXIC-INFECTIOUS SHOCK MODELING | 1999 |
|
RU2173346C2 |
ATTENUATED STRAIN Bacillus anthracis FOR DEVELOPING MEANS OF SPECIFIC PREVENTION OF ANTHRAX | 2013 |
|
RU2544951C1 |
MIXED ANTHRAX VACCINE | 1992 |
|
RU2115433C1 |
METHOD OF IDENTIFICATION OF BACILLUS ANTHRACIS | 2001 |
|
RU2204607C2 |
METHOD OF ANTHRAX BACTERIOPHAGE "GAMMA" CULTURING | 1996 |
|
RU2133273C1 |
METHOD FOR COMPLEX PROPHYLAXIS OF ANTHRAX | 2002 |
|
RU2216349C1 |
Authors
Dates
1999-11-20—Published
1997-07-31—Filed